Press release
Atrial Fibrillation (AF) Ablation Market 2018 to 2028 | Key Players - atrial fibrillation ablation market are Boston Scientific Corporation, Medtronic, AtriCure, Inc. LuxCath LLC, BIOTRONIK UK Ltd, Biosense Webster, Inc, MicroPort Scientific Corporation,
Arterial fibrillation is a disease that creates irregular and rapid heart rate. Atrial fibrillation ablation is performed to treat the disease. The upper chambers of the heart beat irregularly and contract randomly at a very fast rate, out of coordination with the lower ventricles of the heart due to which the time decreases for the heart muscle relaxation. This increases the rate of heart failure and heart strokes and reduces the efficiency and performance of the heart. The symptoms for atrial fibrillation include weakness, heart palpitations, and shortness of breath. The irregular impulses revoke the heart’s natural pacemaker and cannot control the rhythm of the heart. In normal conditions, the heart beats 60–100 times per minute while in case of atrial fibrillation the heart beat changes to about 100–175 beats per minute which is cured by atrial fibrillation ablation.
Get Free Exclusive Sample Copy of This Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2269
Atrial Fibrillation (AF) Ablation Market: Drivers and Restraints
The growing prevalence of coronary heart disease, cardiac diseases such as heart attacks, strokes, high blood pressure, previous heart surgeries is expected to be the major factor driving the growth of the atrial fibrillation ablation market. According to the Center for Disease Control and Prevention (CDC) an estimated of 2.7–6.1 million people are suffering from atrial fibrillation in the U.S. Moreover, almost 750,000 hospitalizations occur every year due to atrial fibrillation which is creating growth opportunities for the atrial fibrillation ablation market. This condition contributes to an estimated 130,000 deaths. Some of the risk factors for atrial fibrillation include increasing age, obesity, diabetes, chronic kidney disease and excessive intake of alcohol. New devices and technologies are being developed for the atrial fibrillation ablation which control the heart rhythms caused by abnormal signals to help patients survive. These devices with minimal invasion provide rapid results and greater efficiency and are used where medications fail. The catheters used for atrial fibrillation ablation provide energy to create an abrasion, which aborts the abnormal electric signals.
Atrial Fibrillation Ablation Market: Overview
Atrial fibrillation ablation is a technique in which the irregular and out-of-synchronized electric signals are treated. For atrial fibrillation ablation two types of technologies are used, i.e., radiofrequency energy and cryoablation. The cryoballon delivers a refrigerant. The tip of the catheters are advanced into the vein which when reach the target freeze the tissue which is in contact with the balloon. While in case of radio frequency energy, heat is passed around the pulmonary veins to create a circular scar which in return will reduce the frequency of atrial fibrillation. The global market of atrial fibrillation is expected to witness high growth over the forecast period. With the advancement of technology, majority of the devices are introduced in the market which generate competition among the local as well as regional players. The market for atrial fibrillation ablation is expected to increase with the rise in the cardiac diseases. The geriatric population is expected to be affected the most.
Ask For Customized Report @ https://www.factmr.com/connectus/sample?flag=RC&rep_id=2269
Atrial Fibrillation (AF) Ablation Market: Regional Outlook
Geographically, the global atrial fibrillation ablation market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to be dominant regional market for atrial fibrillation ablation owing to increasing risk factors such as increasing age, obesity diabetes resulting in cardiac diseases. Also the market in North America will rise due to the advancement in the technology and products, strict regulations for patient care and safety in the region. The atrial fibrillation ablation market in Asia Pacific excluding Japan is expected to grow at a significant CAGR due to increasing geriatric population opting for atrial fibrillation ablation procedures to avoid blood clots and strokes causing death of the patient. In addition, initiatives by the governments in the region on providing better healthcare facilities to the population contribute to the growth of the atrial fibrillation ablation market. Europe is expected to have second large share in the global atrial fibrillation ablation market throughout the forecast period.
Atrial Fibrillation (AF) ablation Market: Key Players
The global market for atrial fibrillation ablation is highly fragmented. Examples of some of the key players operating in the global atrial fibrillation ablation market are Boston Scientific Corporation, Medtronic, AtriCure, Inc. LuxCath LLC, BIOTRONIK UK Ltd, Biosense Webster, Inc, MicroPort Scientific Corporation, Baylis Medical Company, Inc and Lepu (Beijing) Medical Devices Co., Ltd. and AFreeze, among others.
You can Buy This Report from Here @ https://www.factmr.com/checkout/2269/S
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/
Read Industrial News : http://insiderstribune.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Atrial Fibrillation (AF) Ablation Market 2018 to 2028 | Key Players - atrial fibrillation ablation market are Boston Scientific Corporation, Medtronic, AtriCure, Inc. LuxCath LLC, BIOTRONIK UK Ltd, Biosense Webster, Inc, MicroPort Scientific Corporation, here
News-ID: 1695617 • Views: …
More Releases from Fact.MR
Body Area Network Market Forecasted to Expand Rapidly, Projecting US$ 229.8 Bill …
It is anticipated that the worldwide body area network market will expand at a strong 22.3% CAGR. Its anticipated value increased from US$ 24.6 billion in 2021 to around US$ 229.8 billion by 2032.
A new generation of body-attachable wireless body sensors has emerged in response to advancements in wireless communication technology and various physiological sensor types.
Download a Sample Copy Of Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7208
Body Area Networks, or BANs, are becoming a game-changer…
Payroll Outsourcing Services Market Is Likely To Be Valued At US$ 32607.5 Millio …
The global payroll outsourcing services market was valued at US$ 17000 Million in 2022. During the 2023-2033 period of assessment, demand is expected to rise at a 6.1% value CAGR, likely to surpass a valuation of US$ 32607.5 Million by the end of the said forecast period.
The Payroll Outsourcing Services Industry sales study offers a comprehensive analysis on diverse features including production capacities, Payroll Outsourcing Services demand, product developments, sales…
Carotenoids Market Is Forecasted To Reach US$ 2.45 Billion at 5.4% CAGR By 2034: …
With an estimated market size of US$ 1.45 billion in 2024, the global carotenoid market is projected to expand at a CAGR of 5.4% and reach a market value of US$ 2.45 billion by 2034-end. Growth prospects of the market remain optimistic, owing to shifting consumer preferences for natural ingredients, expanding carotenoid applications in a range of industries, and ongoing developments in product development and formulation techniques.
The Carotenoid Industry sales…
Canned Fruits Market Is Anticipated To Reach A Valuation Of US$ 12 Billion By 20 …
The value of the global canned fruits market is US$ 9.8 billion in 2022, which is projected to climb to US$ 12 billion by 2032-end, increasing at a CAGR of 2% through 2032.
The Canned Fruits Industry sales study offers a comprehensive analysis on diverse features including production capacities, Canned Fruits demand, product developments, sales revenue generation and Canned Fruits market outlook across the globe.
market research report by Fact.MR, (Leading business…
More Releases for Atrial
Atrial Fibrillation Stroke Treatment Market Segmentation By Atrial Fibrillation …
The arrhythmia problem occurs due to irregular heartbeats which can cause atrial fibrillation stoke. The irregular manner (increase pattern or lower pattern of heart beats) of heart beating pattern can cause atrial fibrillation stroke. The atrial fibrillation stroke causes major problem of heart and increase heart related problem. The patient which are suffering from atrial fibrillation effect two chamber of heart and atria present below the heart will lead to…
Atrial Fibrillation Market
Atrial Fibrillation Market is predicted to grow at a double digit CAGR over the forecast period (2017 to 2023). Atrial fibrillation, also denoted as AF, is an irregular or fast heart rhythm. It raises the dangers of chest pain, heart strokes, congestive heart failure, or cardiac discomfort. The typical indications of AF are dizziness, confusion, fainting, or tiredness.
Therapeutic advancements and the burgeoning aged populace also drive the industry. Supportive clinical…
Atrial Fibrillation Stroke Treatment Market Segmentation By Atrial Fibrillation …
The arrhythmia problem occurs due to irregular heartbeats which can cause atrial fibrillation stoke. The irregular manner (increase pattern or lower pattern of heart beats) of heart beating pattern can cause atrial fibrillation stroke. The atrial fibrillation stroke causes major problem of heart and increase heart related problem. The patient which are suffering from atrial fibrillation effect two chamber of heart and atria present below the heart will lead to…
Atrial Fibrillation Market Opportunity Analysis, 2018-2026
Atrial fibrillation, also known as A-fib or AF, is an irregular heartbeat exemplified by rapid and abnormal beating of the heart. Most episodes of atrial fibrillation have no symptoms or fewer symptoms such as intermittent heart palpitations, lightheadedness, fainting, chest pain, and shortness of breath. Atrial fibrillation is linked with an elevated risk of heart failure, stroke, and dementia. The disease is a kind of supraventricular tachycardia. Risk factors associated…
Atrial Septal Defect Market Future Opportunities2017 - 2025
Global Atrial Septal Defect Market: Outlook
Atrial septal defect is one of the most common congenital cardiac diseases and usually affects women more than men. It is characterized by a hole or defect in the interatrial septum that separates the heart’s two upper chambers, i.e., atria. The opening in the septum usually closes when the baby is born, but in few cases if the opening does not close, the hole…
Atrial Fibrillation Market Analysis, Forecast, and Assessment 2026
Increasing prevalence of common diseases and conditions such as obesity, diabetes, hypertension, etc., are leading to the risk of various heart problems. Moreover, the rise in people suffering from high blood pressure, and valvular heart disease due to the rheumatic fever are some of the most common risk factors for atrial fibrillation. Along with the increasing number of people suffering from atrial fibrillation, especially among the geriatric population. There has…
